Determining the metabolic effects of dietary fat, sugars and fat-sugar interaction using nutritional geometry in a dietary challenge study with male mice.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
21 07 2023
21 07 2023
Historique:
received:
06
12
2022
accepted:
10
07
2023
medline:
23
10
2023
pubmed:
22
7
2023
entrez:
21
7
2023
Statut:
epublish
Résumé
The metabolic effects of sugars and fat lie at the heart of the "carbohydrate vs fat" debate on the global obesity epidemic. Here, we use nutritional geometry to systematically investigate the interaction between dietary fat and the major monosaccharides, fructose and glucose, and their impact on body composition and metabolic health. Male mice (n = 245) are maintained on one of 18 isocaloric diets for 18-19 weeks and their metabolic status is assessed through in vivo procedures and by in vitro assays involving harvested tissue samples. We find that in the setting of low and medium dietary fat content, a 50:50 mixture of fructose and glucose (similar to high-fructose corn syrup) is more obesogenic and metabolically adverse than when either monosaccharide is consumed alone. With increasing dietary fat content, the effects of dietary sugar composition on metabolic status become less pronounced. Moreover, higher fat intake is more harmful for glucose tolerance and insulin sensitivity irrespective of the sugar mix consumed. The type of fat consumed (soy oil vs lard) does not modify these outcomes. Our work shows that both dietary fat and sugars can lead to adverse metabolic outcomes, depending on the dietary context. This study shows how the principles of the two seemingly conflicting models of obesity (the "energy balance model" and the "carbohydrate insulin model") can be valid, and it will help in progressing towards a unified model of obesity. The main limitations of this study include the use of male mice of a single strain, and not testing the metabolic effects of fructose intake via sugary drinks, which are strongly linked to human obesity.
Identifiants
pubmed: 37479702
doi: 10.1038/s41467-023-40039-w
pii: 10.1038/s41467-023-40039-w
pmc: PMC10362033
doi:
Substances chimiques
Sugars
0
Dietary Sucrose
0
Dietary Fats
0
Glucose
IY9XDZ35W2
Fructose
30237-26-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4409Informations de copyright
© 2023. The Author(s).
Références
Br J Nutr. 2013 Oct;110(7):1178-87
pubmed: 23651522
Cell Metab. 2018 Sep 4;28(3):415-431.e4
pubmed: 30017356
Cardiovasc Res. 2021 Jan 21;117(2):386-401
pubmed: 32386289
Cell Metab. 2018 Oct 2;28(4):656-666.e1
pubmed: 30017358
J Biol Chem. 2011 Jun 10;286(23):20991-1001
pubmed: 21515678
Cell. 2015 Mar 26;161(1):18-23
pubmed: 25815981
Obesity (Silver Spring). 2019 Jun;27(6):879-887
pubmed: 31054268
Annu Rev Physiol. 2016;78:223-41
pubmed: 26654352
Sci Rep. 2016 Apr 29;6:25091
pubmed: 27125896
J Dev Orig Health Dis. 2016 Feb;7(1):73-82
pubmed: 26511158
Eur J Clin Nutr. 2022 Sep;76(9):1209-1221
pubmed: 35896818
Nat Med. 2021 Feb;27(2):344-353
pubmed: 33479499
Diabetes Care. 1995 Feb;18(2):245-50
pubmed: 7729306
Obesity (Silver Spring). 2019 Aug;27(8):1225-1238
pubmed: 31339001
Nutrients. 2014 Jul 15;6(7):2632-49
pubmed: 25029210
Obes Rev. 2005 May;6(2):133-42
pubmed: 15836464
Physiol Behav. 2004 Jul;81(5):755-64
pubmed: 15234181
Int J Obes Relat Metab Disord. 2000 Dec;24(12):1545-52
pubmed: 11126204
Nat Metab. 2021 Jun;3(6):810-828
pubmed: 34099926
J Nutr. 1993 Nov;123(11):1939-51
pubmed: 8229312
J Clin Endocrinol Metab. 2011 Mar;96(3):861-8
pubmed: 21252253
J Biosci Bioeng. 2018 Jan;125(1):131-139
pubmed: 28847578
Science. 2018 Nov 16;362(6416):764-770
pubmed: 30442800
J Gerontol A Biol Sci Med Sci. 2015 Oct;70(10):1181-8
pubmed: 25313149
Nutrients. 2020 May 21;12(5):
pubmed: 32455838
Obes Rev. 2009 Jan;10(1):68-75
pubmed: 18764885
Cell Metab. 2010 Jul 7;12(1):10-7
pubmed: 20620991
Proc Biol Sci. 2019 May 15;286(1902):20190393
pubmed: 31039722
Am J Clin Nutr. 2006 Aug;84(2):274-88
pubmed: 16895873
Sci Rep. 2016 Dec 06;6:38513
pubmed: 27922100
Medscape J Med. 2008 Jul 09;10(7):160
pubmed: 18769702
BMJ. 2018 Jun 13;361:k2340
pubmed: 29898880
Physiol Rev. 2010 Jan;90(1):23-46
pubmed: 20086073
Front Nutr. 2020 Jul 06;7:75
pubmed: 32733909
Obesity (Silver Spring). 2019 Nov;27(11):1761-1768
pubmed: 31689013
Physiol Behav. 2022 Jan 1;243:113644
pubmed: 34767835
Eur J Nutr. 2013 Apr;52(3):1181-9
pubmed: 22847642
Eur J Clin Nutr. 2007 Dec;61 Suppl 1:S40-74
pubmed: 17992186
J Clin Invest. 2017 Nov 1;127(11):4059-4074
pubmed: 28972537
Science. 2021 May 7;372(6542):577-578
pubmed: 33958466
Cell Metab. 2021 Dec 7;33(12):2314-2315
pubmed: 34699743
Bonekey Rep. 2016 Oct 26;5:845
pubmed: 27818742
Am J Clin Nutr. 2004 Apr;79(4):537-43
pubmed: 15051594
Cell Metab. 2014 Mar 4;19(3):418-30
pubmed: 24606899
J Lipid Res. 2014 Dec;55(12):2541-53
pubmed: 25271296
Am J Clin Nutr. 2007 Nov;86(5):1354-63
pubmed: 17991646
Front Nutr. 2022 Feb 17;9:828522
pubmed: 35284452
Nat Commun. 2017 Mar 14;8:14689
pubmed: 28290443
Lancet Diabetes Endocrinol. 2015 Dec;3(12):968-79
pubmed: 26527511
Am J Clin Nutr. 2022 May 1;115(5):1243-1254
pubmed: 35134825